Hikal Ltd. — Investor Relations & Filings
Hikal Ltd. provides solutions across the life sciences value chain, specializing in the development and manufacturing of active ingredients, intermediates, and formulations. The company operates through two primary business segments: Pharmaceuticals and Crop Protection. In the pharmaceutical division, it focuses on the production of Active Pharmaceutical Ingredients (APIs) and advanced intermediates for various therapeutic areas. The crop protection segment involves the contract manufacturing of pesticides, herbicides, and fungicides for global agrochemical leaders. Hikal offers comprehensive Contract Research and Manufacturing Services (CRAMS), leveraging its research and development capabilities to support clients from early-stage development to commercial-scale production. Its facilities adhere to international quality standards, maintaining a strong track record of regulatory compliance with global health authorities.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Board Meeting — Financial Results | 2023-08-01 | English | |
| Updates | 2023-07-23 | English | |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2023-07-17 | English | |
| Disclosure under SEBI Takeover Regulations | 2023-06-30 | English | |
| Trading Window | 2023-06-29 | English | |
| Disclosure under SEBI Takeover Regulations | 2023-06-28 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 43992430 | Board Meeting — Financial Results | 2023-08-01 | English | ||
| 42830007 | Updates | 2023-07-23 | English | ||
| 42811667 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2023-07-17 | English | ||
| 42836478 | Disclosure under SEBI Takeover Regulations | 2023-06-30 | English | ||
| 42780397 | Trading Window | 2023-06-29 | English | ||
| 42796767 | Disclosure under SEBI Takeover Regulations | 2023-06-28 | English | ||
| 42822650 | Analysts/Institutional Investor Meet/Con. Call Updates | 2023-06-02 | English | ||
| 42807636 | Trading Window | 2023-05-31 | English | ||
| 42814608 | Analysts/Institutional Investor Meet/Con. Call Updates | 2023-05-31 | English | ||
| 42879383 | Annual Secretarial Compliance Report | 2023-05-30 | English | ||
| 42897195 | Related Party Transactions | 2023-05-29 | English | ||
| 42906072 | Analysts/Institutional Investor Meet/Con. Call Updates | 2023-05-29 | English | ||
| 42926924 | Investor Presentation | 2023-05-29 | English | ||
| 42926909 | Press Release | 2023-05-29 | English | ||
| 42927336 | Dividend | 2023-05-29 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Hikal Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/61437/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=61437 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=61437 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=61437 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 61437}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Hikal Ltd. (id: 61437)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.